The new Manchester Cancer Research Centre (MCRC) will integrate the cancer research efforts of The University of Manchester, the Christie Hospital, the Paterson Institute for Cancer Research and Cancer Research UK, giving Manchester one of the largest cancer research and treatment centers in Europe.
Significant new investment – estimated at GBP30 million to GBP50 million – is expected to be secured to fund world-class researchers, laboratories and patient research facilities, with the aim of doubling cancer research activity in the city over the next five years.
As part of the arrangements, the Paterson Institute would become a research institute of the university, enabling a full integration of the fundamental and clinical research activities of each.
This would ensure that the latest research findings on the causes of cancer are translated quickly into earlier detection methods and new treatments for patients. It would also enable laboratory scientists, clinical investigators and doctors to work collaboratively together, integrating current cancer research programs and developing new strategies.
“As the largest funding partner of the proposed MCRC, Cancer Research UK is extremely excited about these developments in Manchester,” said Alex Markham, chief executive of Cancer Research UK. “As long term supporters of the Christie, The Paterson Institute, and the University it is terrific to see the Manchester cancer research community taking its rightful place as an international leader.”